Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|March 10, 2017
Top 10 Primary Care Drugs Approved in Early 2017
Author(s)Leo Robert
Click through this slide summary for a look at some of the more significant approvals so far for primary care.
Advertisement
Just shy of 3 months into the new year, the FDA has already granted a number of new drug approvals and new indications for drugs already approved. Scroll through the slides above for a look at some of the more significant recent approvals for primary care.For a quick review of last year’s approvals, go to Top 20 Primary Care Drugs Approved in 2016. SOURCESCenterWatch: 2016 FDA Approved DrugsDrugs.com: New Drug ApprovalsÂ
Advertisement
Related to this article
EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Diagnoses Documented in Just 7.8% of Midlife Women's Outpatient Visits, Study Finds
2
JoAnn Pinkerton, MD, on Counseling Patients Starting Elinzanetant for VMS
3
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
4
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
5